| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 47 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Manning Meredith | Chief Commercial Officer | Sale+OE | 45,249 | $67.28 | $3,044,342.88 | -9.5% | +27.3% | -55.4% | |
| Mar 27, 2025 | MacKaness James H | Chief Financial Officer | Sale+OE | 90,622 | $69.44 | $6,293,177.03 | -6.7% | +27.3% | -55.4% | |
| Mar 27, 2025 | Huang Michael F. | Sr. VP Of Clinical Development | Sale+OE | 14,583 | $69.51 | $1,013,627.05 | -4.1% | +27.3% | -55.4% | |
| Jan 3, 2025 | MacKaness James H | Chief Financial Officer | Sell | 7,874 | $45.78 | $360,460.44 | -2.3% | +55.3% | +1.5% | |
| Jan 3, 2025 | Hirano Patricia C | See Remarks | Sell | 3,030 | $45.78 | $138,709.47 | -0.9% | +55.3% | +1.5% | |
| Jan 3, 2025 | Anish Bhatnagar | Chief Executive Officer | Sell | 21,091 | $45.78 | $965,515.52 | -1.0% | +55.3% | +1.5% | |
| Jan 3, 2025 | Yen Kristen | See Remarks | Sell | 4,860 | $45.78 | $222,483.86 | -2.0% | +55.3% | +1.5% | |
| Oct 1, 2024 | Anish Bhatnagar | Chief Executive Officer | Sell | 21,633 | $49.43 | $1,069,306.22 | -1.5% | -8.7% | +21.1% | |
| Oct 1, 2024 | MacKaness James H | Chief Financial Officer | Sell | 8,077 | $49.43 | $399,241.39 | -3.3% | -8.7% | +21.1% | |
| Oct 1, 2024 | Yen Kristen | See Remarks | Sell | 3,108 | $49.43 | $153,626.63 | -1.9% | -8.7% | +21.1% |